Malignant ovarian germ cell tumors: Analysis of 3 2 cases

Objective: In this study, some clinicopathologic characteristics and the outcome of patients with malignant ovarian germ cell tumors (MOGCT) were evaluated.

Materials and Methods: The clinical charts and pathologic reports of 32 patients with MOGCT treated at the Department of Obstetrics and Gynecology, and diagnosed at the Department of Pathology, Medical Faculty of Dicle University, Turkey from 1983 to 1999 were reviewed.

Results: Thirteen patients (40.6%) had dysgerminoma, nine (28. l %) had immature teratoma (four grade I, three grade 2, and two grade 3), eight (25%) had endodermal sinus tumor, and two (6.3%) patients had mixed germ cell tumors. Site of involvement was unilateral in 30 (l 9 on the right and 11 on the left) and bilateral in two. All patients underwent primary surgery and 26 patients combination chemotherapy. There seemed to be a relationship between pathologic findings and clinical outcome, and MOGCT histologic types may affect the prognosis.

Conclusion: Dysgerminoma had a better prognosis than the nondysgerminomatous group (p < 0.05). This study provides additional data in confirmation of previous reports that management of MOGCT with fertility preservation is safe.

Malignant ovarian germ cell tumors; Chemotherapy; Treatment; Fertility

[1] Gershenson D.M.: "Update on malignant ovarian germ cell tumours". Cancer, 1993, 71, 1581.

[2] Kusamura S., Teixeira L.C., Santos M.A., de Angelo Andrade L.A., Torres J.C.C., Sagarra A. et al.: "Ovarian germ cell cancer: clinicopathologic analysis and outcome of 31 cases". Tumori, 2000, 86, 450.

[3] Nawa A., Obata N., Kikkawa F., Kawai M., Nagasaka T., Goto S., et al.: "Prognostic factors of paitents with yolk sac tumors of the ovary". Am. J. Obstet. Gynecol., 2001, 184, 1182.

[4] Talerman A.: "Germ cell tumors of the ovary": In: Blaustein's Pathology of the Female Genital Tract. Kurman, R.J. (ed.) 5"'ed., New York, Springer-Verlag, 2002, 967.

[5] Tewari K., Cappuccini F., Disaia P.J., Berman M.L., Manetta A., Kohler M.F.: "Malignant germ cell tumors of the ovary". Obstet Gynecol., 2000, 95, 128.

[6] Mitchell P.L., Al-Nasiri N., A'Hern R., F isher C., Horwich A., Pinkerton C.R. et al.:'Treatment of nondysgerminatous ovarian germ cell tumors. Analysis of 69 cases". Cancer, 1999, 85, 2232.

[7] Scully R.E.: "Histological typing of ovarian tumours". World Health Organisation Histological Classification of Tumours, 2"d ed., Heidelberg, Springer, 1999.

[8] Norris H.J., Zirkin H.J., Benson W.L.: "Immature (malignant) teratoma of the ovary. A clinical and pathologic study of 58 cases" Cancer, 1976, 37, 2359.

[9] Ezzat A., Raja M., Bakri Y., Subhi J., Memon M., Schwartz P. et al.: "Malignant ovarian germ cell tumours. A survival and prognostic analysis". Acta Oneal., 1999, 38, 455.

[10] Zanetta G., Bonazzi C., Cantu M.G., Bini S., Locatelli A., Bratina G et al.: "Survival and reproductive function after treatment of malignant germ cell ovarian tumors". J. Clin. Oneal., 2001, 19, 1015.

[11] Heifetz S.A., Cushing B., Giller R., Shuster J.J., Stolar C.J., Vinocur C.D. et al.: "Immature teratomas in children: Pathologic considerations". Am. J. Surg. Pathol., 1998, 22, 1115.

[12] Wisniewski M., Deppich L.M.: "Solid teratomas of the ovary". Cancer, 1973, 32, 440.

[13] Schwartz P.E., Chambers S.K., Chambers J.T., Kohom E., Mclntosh S.: "Ovarian germ cell malignancies: the Yale University experience". Gynecol. Oneal., 1992, 45, 26.

[14] Germa J.R., Izquierdo M.A., Segui M.A., Climent M.A., Ojeda B., Alonso C.: "Malignant ovarian germ cell tumors: the experience at the Hospital de Ia Santa Creu i Sant Pau". Gynecol. Oneal., 1992, 45, 153.

[15] Kanazawa K., Suzuki T., Sakumoto K.: "Treatment of malignant ovarian germ cell tumors with preservation of fertility". Am. J. Clin. Oneal., 2000, 23, 244.

[16] Peccatori F., Bonazzi C., Chiari S., Landoni F., Colombo N., Mangioni C.: "Surgical management of malignant ovarian germcell tumours: 10 years'experience of 129 patients". Obstet. Gynecol., 1995, 86, 367.

[17] Cheung M.M., Lau W.H., Chan M., Teng S.K., Chan J.K., Ngan R.K. et al.: "Experience with the management of ovarian germ cell tumors in Chinese patients". Gynecol. Oneal., 1994, 52, 306.

[18] Gershenson D.M., Copeland L.J., Kavanagh J.J., Cangir A., Del Jungo G., Saul P.B. et al.: "Treatment of malignant nondysgerminomatous germ cell tumors of the ovary with vincristine, dactinomycin, and cyclophosphamide". Cancer, 1985, 56, 2756.

[19] Culine S., Lhome C., Kattan J., Michel G., Duvillard P., Droz J.P.: "Cisplatin-based chemotherapy in the management of germ cell tumors of the ovary: The Institute Gustave Roussy Experience". Gynecol. Oneal., 1997, 64, 160.

[20] Piura B., Dgani R., Zale! Y., Nemet D., Yanai-Inbar I., Cohen Y. et al.: "Malignant germ cell tumors of the ovary: A study of 20 cases". J. Surg. Oneal., 1995, 59, 155.

[21] Williams S., Blessing J.A., Liao S.Y., Ball H., Hanjani P.: "Adjuvant therapy of ovarian germ cell tumors with cisplatin, etoposide, and bleomycin: a trial of the Gynecologic Oncology Group". J. Clin. Oneal., 1994, 12, 701.

[22] Williams S.D., Blessing J.A., DiSaia P.J., Major F.J., Ball H.G., Liao S.Y.: "Second look laparotomy in ovarian germcell tumors: the Gynecologic Oncology Group experience". Gynecol. Oneal., 1994, 52, 287.

[23] Uzunlar A.K., Yalinkaya A., Yaldiz M., Kilinc N., Gul T.: "Survival and reproductive function after treatment of immature ovarian teratoma". Eur. J. Gynaecol. Oneal., 2001, 22, 384.